chr15-89669579-C-A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_002666.5(PLIN1):​c.692G>T​(p.Arg231Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,613,954 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 15 hom., cov: 31)
Exomes 𝑓: 0.00076 ( 17 hom. )

Consequence

PLIN1
NM_002666.5 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.46

Publications

4 publications found
Variant links:
Genes affected
PLIN1 (HGNC:9076): (perilipin 1) The protein encoded by this gene coats lipid storage droplets in adipocytes, thereby protecting them until they can be broken down by hormone-sensitive lipase. The encoded protein is the major cAMP-dependent protein kinase substrate in adipocytes and, when unphosphorylated, may play a role in the inhibition of lipolysis. Alternatively spliced transcript variants varying in the 5' UTR, but encoding the same protein, have been found for this gene. [provided by RefSeq, Feb 2009]
PLIN1 Gene-Disease associations (from GenCC):
  • PLIN1-related familial partial lipodystrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 15-89669579-C-A is Benign according to our data. Variant chr15-89669579-C-A is described in ClinVar as Benign. ClinVar VariationId is 393438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0077 (1172/152226) while in subpopulation AFR AF = 0.0267 (1108/41530). AF 95% confidence interval is 0.0254. There are 15 homozygotes in GnomAd4. There are 553 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1172 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLIN1NM_002666.5 linkc.692G>T p.Arg231Leu missense_variant Exon 6 of 9 ENST00000300055.10 NP_002657.3 O60240
PLIN1NM_001145311.2 linkc.692G>T p.Arg231Leu missense_variant Exon 6 of 9 NP_001138783.1 O60240

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLIN1ENST00000300055.10 linkc.692G>T p.Arg231Leu missense_variant Exon 6 of 9 1 NM_002666.5 ENSP00000300055.5 O60240
PLIN1ENST00000430628.2 linkc.692G>T p.Arg231Leu missense_variant Exon 6 of 9 5 ENSP00000402167.2 O60240

Frequencies

GnomAD3 genomes
AF:
0.00769
AC:
1169
AN:
152108
Hom.:
15
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0267
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.00189
AC:
475
AN:
251272
AF XY:
0.00138
show subpopulations
Gnomad AFR exome
AF:
0.0248
Gnomad AMR exome
AF:
0.00133
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000762
AC:
1114
AN:
1461728
Hom.:
17
Cov.:
33
AF XY:
0.000715
AC XY:
520
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.0252
AC:
845
AN:
33480
American (AMR)
AF:
0.00152
AC:
68
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53328
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5764
European-Non Finnish (NFE)
AF:
0.0000477
AC:
53
AN:
1111948
Other (OTH)
AF:
0.00215
AC:
130
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
62
124
187
249
311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00770
AC:
1172
AN:
152226
Hom.:
15
Cov.:
31
AF XY:
0.00743
AC XY:
553
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0267
AC:
1108
AN:
41530
American (AMR)
AF:
0.00307
AC:
47
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68002
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
57
114
171
228
285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00191
Hom.:
6
Bravo
AF:
0.00847
ESP6500AA
AF:
0.0255
AC:
112
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00244
AC:
296
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Monogenic diabetes Benign:1
Feb 08, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BP4 (REVEL 0.073 + 7 predictors), BP5 (found in case with alternate cause), BA1 (2.5% MAF in gnomAD African)= benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
2.5
DANN
Uncertain
0.98
DEOGEN2
Benign
0.23
T;T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.73
.;T
MetaRNN
Benign
0.018
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.9
M;M
PhyloP100
-2.5
PrimateAI
Benign
0.19
T
PROVEAN
Uncertain
-3.5
D;D
REVEL
Benign
0.073
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.041
D;D
Polyphen
0.76
P;P
Vest4
0.41
MVP
0.055
MPC
0.059
ClinPred
0.053
T
GERP RS
-4.7
Varity_R
0.23
gMVP
0.39
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.45
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.45
Position offset: -14

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114583540; hg19: chr15-90212810; API